Company filings profile · CIK 0001873835
Immix Biopharma, Inc. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for Immix Biopharma, Inc. (IMMX): 7 filings in the last 90 days vs 21 in the prior 90 (filing-velocity cooling ↓ · 0.33×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Sep 30, 2026. Source-linked, daily-refreshed.
Material 8-K events — Immix Biopharma, Inc.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Sep 29, 2026 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | ↗ |
| Jul 20, 2026 | Other Events | ↗ |
| May 29, 2026 | Item 5.07 | ↗ |
| May 21, 2026 | Other Events; Financial Statements and Exhibits | ↗ |
| May 21, 2026 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | ↗ |
| Mar 30, 2026 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | ↗ |
| Mar 25, 2026 | Entry into a Material Agreement; Financial Statements and Exhibits | ↗ |
Watch Immix Biopharma, Inc. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Sep 29, 2026 | FWP | FWP | ↗ |
| Sep 29, 2026 | 424B5 | 424B5 | ↗ |
| Sep 29, 2026 | 8-K | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | ↗ |
| Aug 14, 2026 | SCHEDULE 13G | ↗ | |
| Aug 13, 2026 | SCHEDULE 13G/A | ↗ | |
| Aug 7, 2026 | 10-Q | 10-Q | ↗ |
| Jul 20, 2026 | 8-K | Other Events | ↗ |
| Jun 5, 2026 | SCHEDULE 13G/A | ↗ | |
| May 29, 2026 | 8-K | Item 5.07 | ↗ |
| May 29, 2026 | 4 | 4 | ↗ |
| May 29, 2026 | 4 | 4 | ↗ |
| May 29, 2026 | 4 | 4 | ↗ |
| May 29, 2026 | 4 | 4 | ↗ |
| May 29, 2026 | 4 | 4 | ↗ |
| May 29, 2026 | 4 | 4 | ↗ |
| May 29, 2026 | 4 | 4 | ↗ |
| May 29, 2026 | 4 | 4 | ↗ |
| May 29, 2026 | 4 | 4 | ↗ |
| May 21, 2026 | 8-K | Other Events; Financial Statements and Exhibits | ↗ |
| May 21, 2026 | 424B5 | 424B5 | ↗ |
| May 21, 2026 | FWP | FWP | ↗ |
| May 21, 2026 | 8-K | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | ↗ |
| May 15, 2026 | SCHEDULE 13G/A | ↗ | |
| May 7, 2026 | 10-Q | 10-Q | ↗ |
| May 4, 2026 | SCHEDULE 13G/A | ↗ | |
| Apr 6, 2026 | ARS | ARS | ↗ |
| Apr 6, 2026 | DEFA14A | DEFA14A | ↗ |
| Apr 6, 2026 | DEF 14A | DEF 14A | ↗ |
| Mar 30, 2026 | 8-K | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | ↗ |
| Mar 27, 2026 | 10-K/A | 10-K/A | ↗ |
| Mar 25, 2026 | S-8 | S-8 | ↗ |
| Mar 25, 2026 | 8-K | Entry into a Material Agreement; Financial Statements and Exhibits | ↗ |
| Mar 25, 2026 | 424B5 | 424B5 | ↗ |
| Mar 25, 2026 | 10-K | 10-K | ↗ |
| Mar 20, 2026 | SCHEDULE 13G | ↗ | |
| Feb 17, 2026 | SCHEDULE 13G | ↗ | |
| Feb 17, 2026 | SCHEDULE 13G | ↗ | |
| Jan 22, 2026 | EFFECT | Item ; Item ; Item | ↗ |
| Jan 16, 2026 | CORRESP | ↗ | |
| Jan 16, 2026 | UPLOAD | ↗ |